USPTO serial 79413262
N-TAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 7, 2025
- Examiner
- MARTYNOV,VIKTORIIA V
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with N-TAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew M. Smith
Andrew M. Smith Resonate IP, LLCP.O. Box 1650Bend, OR 97709United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, namely, drug delivery agents in the form of tablets that enable oral delivery of proteins and peptides; pharmaceutical preparations for use as peptide replacement therapy; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of metabolic conditions; pharmaceutical preparations for the treatment of short bowel syndrome; pharmaceutical preparations for the treatment of stress fractures; drug delivery agents in the form of tablets consisting of compounds that facilitate the delivery of pharmaceutical preparations | ACTIVE | — |
| 042 | Research and development services in the field of pharmaceutical preparations; development of pharmaceutical preparations and medicines; scientific research in the medical and pharmaceutical field, and consultancy and information relating thereto; design and development of new technology for others relating to oral delivery of proteins and peptides, and consultancy and information services relating thereto; research and development in the field of drug delivery systems | ACTIVE | — |
| 045 | licensing of intellectual property; licensing of technology, namely, licensing of oral drug delivery technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Entera Bio Ltd.
- Other trademarks owned by Entera Bio Ltd.
- Other trademarks owned by Entera Bio Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named N-TAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 30, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 15, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 15, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 7, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 3, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 19, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 19, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 1, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 1, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 26, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 25, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |